Navigation Links
Echo Therapeutics and Cato BioVentures Sign Right of First Offer Agreement for Dermatology Products and Transdermal Drug Delivery Technologies
Date:4/21/2008

, transdermal continuous glucose monitoring (tCGM) system for people with diabetes and for use in hospital critical care units. Echo is also developing a wide range of proprietary transdermal reformulations of FDA-approved pharmaceutical products.

About Cato BioVentures

Cato BioVentures is the venture capital affiliate of Cato Research Ltd., a global contract research and development organization. For 20 years, Cato BioVentures has assisted entrepreneurs and established management teams in building successful pharmaceutical and biotechnology companies. Through strategic CRO service agreements with Cato Research, Cato BioVentures invests its in-kind CRO Service Capital(TM) in innovative products and technologies, giving promising companies immediate access to a broad range of essential CRO services on a noncash basis.

About Cato Research

Founded in 1988 by Dr. Allen Cato and Lynda Sutton and headquartered near Research Triangle Park, Cato Research is a global full-service contract research and development organization (CRO) providing strategic and tactical support for clients in the pharmaceutical, biotechnology and medical device industries. Cato Research has a staff of over 300 located in offices in the United States, European Union, Canada, Israel, and South Africa.

Cautionary Statement Regarding Forward Looking Statements

Any statements contained in this press release that do not describe historical facts may constitute forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995. Any forward- looking statements contained herein are based on current expectations, but are subject to a number of risks and uncertainties. The factors that could cause actual future results to differ materially from current expectations include, but are not limited to, risks related to Echo's or its partners' ability to identify and obtain additional dermatology product candidates or transdermal dru
'/>"/>

SOURCE Echo Therapeutics
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Prime Therapeutics Receives TIPPS Certification
2. Adams Respiratory Therapeutics to Celebrate 10th Anniversary of its Incorporation on September 12
3. Transition Therapeutics Announces Fiscal 2007 Year End Financial Results
4. Lorus Therapeutics announces election of three new Directors and appoints a new Chairman
5. Deane F. Johnson Center for Neurotherapeutics to Launch First Mobile Medical Unit on October 4th
6. Russell Investment Group Advises Protalix Biotherapeutics of Index Adjustment
7. Adams Respiratory Therapeutics Announces FDA Approval of Grape-Flavored Delsym(R)
8. Prime Therapeutics Announces URAC Accreditation
9. Cell Therapeutics, Inc. (CTI) to Present at BIO Investor Forum
10. Horizon Therapeutics, Inc. Scheduled to Present at Upcoming BioPartnering Europe Meeting
11. Sontra Medical Corporation Changes Name to Echo Therapeutics, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2013)... no-strings sexual encounters are increasingly common on college ... others to "hook up"? A new study by ... and Preventive Medicine, published online by the ... certain factors and behaviors associated with sexual hookups, ... the potential for negative emotional and physical health ...
(Date:6/19/2013)... that block the body,s system for repairing damage to ... As unlikely as it may seem, those compounds are ... cancers driven by a mutation in BRCA, a gene ... carries the mutation. The compounds, termed PARP inhibitors, are ... edition of Chemical & Engineering News . C&EN ...
(Date:6/19/2013)... Center and colleagues at Louisiana State University have developed ... immediate therapy. It relies on understanding the genetic interaction ... better predict a prostate cancer,s aggressiveness to avoid unnecessary ... the online journal PLOS ONE in April. ... 20 percent of all cancers and 9 percent of ...
(Date:6/19/2013)... Hills, CA (PRWEB) June 19, 2013 ... Hills, permits some patients to quit using drugs while ... and Adi Jaffe, the founders of Alternatives, believe that ... Bottom” before they enter treatment and that this approach ... 22 million people in the United States need treatment ...
(Date:6/19/2013)... (PRWEB) June 19, 2013 Many ... deem it medically necessary, according to a ... Child Health Journal. The results of this research ... more than a decade – that trying-to-conceive women ... maintaining a healthy body weight. Fairhaven Health is ...
Breaking Medicine News(10 mins):Health News:Why are some college students more likely to 'hook up'? 2Health News:Moffitt Cancer Center researchers identify genetic variants predicting aggressive prostate cancers 2Health News:Top L.A. Addiction Experts Assert That an Abstinence-Only Approach to Addiction Keeps 85% of Addicts From Seeking Treatment 2Health News:Top L.A. Addiction Experts Assert That an Abstinence-Only Approach to Addiction Keeps 85% of Addicts From Seeking Treatment 3Health News:Fairhaven Health's Dr. Amos Grunebaum Says Fertility Awareness Leads to Babies 2Health News:Fairhaven Health's Dr. Amos Grunebaum Says Fertility Awareness Leads to Babies 3Health News:Fairhaven Health's Dr. Amos Grunebaum Says Fertility Awareness Leads to Babies 4
... N.Y. -- Proper design of computational tools is critical ... patient-care settings, particularly in hospital emergency rooms, a field ... and other institutions recently revealed. , ... are replacing traditional, dry-erase patient status boards, according to ...
... could aid efforts to prevent osteoporosis, researchers say , , MONDAY, ... have lower bone mass than do non-depressed women in the ... bone loss was most pronounced in certain regions of the ... of the most serious -- and potentially fatal -- consequences ...
... and depression often go hand-in-hand for new mothers, according ... Preventive Medicine by Temple University researcher Dr. Robert Whitaker. ... mothers health, the combination may also affect the health ... the potential consequences of maternal smoking include sudden infant ...
... National campaign to support the life-saving mission of St. ... for desperately ill children in communities everywhere, NEW ... five,buildings in five cities across the country will illuminate ... ongoing search for cures,for cancer and other catastrophic diseases ...
... for Health Promotion and,Awareness, ST. LOUIS, Nov. ... voluntary health organization in,the fight against diabetes, announced ... Medal for Health Promotion and Awareness at the,organization,s ... 17, in St. Louis, Missouri., The C. ...
... of TriWest -, PHOENIX, Nov. 26 TriWest Healthcare ... Service members as a,presenting sponsor of Gary Sinise and the ... will also sponsor counselors from the,Tragedy Assistance Program for Survivors ... eternal gratitude to the families of the men and,women in ...
Cached Medicine News:Health News:Design of patient tracking tools may have unintended consequences 2Health News:Design of patient tracking tools may have unintended consequences 3Health News:Depression Linked to Bone Loss in Younger Women 2Health News:Smoking and depression often co-occur in new mothers 2Health News:Buildings Across The Country Join St. Jude Children's Research Hospital(R) For Fourth Annual Thanks and Giving(R) Campaign, Asking America To Help Save Children's Lives While Shopping For The Holidays 2Health News:Buildings Across The Country Join St. Jude Children's Research Hospital(R) For Fourth Annual Thanks and Giving(R) Campaign, Asking America To Help Save Children's Lives While Shopping For The Holidays 3Health News:Buildings Across The Country Join St. Jude Children's Research Hospital(R) For Fourth Annual Thanks and Giving(R) Campaign, Asking America To Help Save Children's Lives While Shopping For The Holidays 4Health News:AARP Receives American Diabetes Association's Distinguished Service Award 2Health News:AARP Receives American Diabetes Association's Distinguished Service Award 3Health News:TriWest Sponsors Lt. Dan Band Performance for Families of Fallen Service Members at Snowball Express Gala 2
(Date:6/19/2013)... ZIONA, Israel , June 19, ... that results from a phase I study in volunteers, ... advanced Parkinson,s patients, of ND0612, were presented at the ... ND0612 is a proprietary levodopa/carbidopa liquid drug formula under ... patch that would maintain constant levodopa plasma concentrations. ...
(Date:6/19/2013)... , June 19, 2013   Life ... announces a licensing agreement granting Suzhou Ribo Life ... manufacture siRNA therapeutics in China ... will formulate proprietary siRNA molecules in combination with ... to address human diseases with high unmet medical ...
(Date:6/19/2013)... INDIANAPOLIS , 19. Juni 2013 ... bekannt, dass mit der Entwicklung von ... bahnbrechender Schritt in der Beschichtung mit ... die Vorteile von biokompatiblem Parylene mit ... effektive Beseitigung schädlicher Mikroorganismen auf beschichteten ...
Breaking Medicine Technology:NeuroDerm Announces Presentation of Data from Studies Evaluating ND0612, an Investigational Levodopa Continuous Administration Drug, in Healthy Volunteers and in Patients with Advanced Parkinson's Disease 2NeuroDerm Announces Presentation of Data from Studies Evaluating ND0612, an Investigational Levodopa Continuous Administration Drug, in Healthy Volunteers and in Patients with Advanced Parkinson's Disease 3NeuroDerm Announces Presentation of Data from Studies Evaluating ND0612, an Investigational Levodopa Continuous Administration Drug, in Healthy Volunteers and in Patients with Advanced Parkinson's Disease 4NeuroDerm Announces Presentation of Data from Studies Evaluating ND0612, an Investigational Levodopa Continuous Administration Drug, in Healthy Volunteers and in Patients with Advanced Parkinson's Disease 5NeuroDerm Announces Presentation of Data from Studies Evaluating ND0612, an Investigational Levodopa Continuous Administration Drug, in Healthy Volunteers and in Patients with Advanced Parkinson's Disease 6Life Technologies Signs Licensing Agreement with Suzhou Ribo Life Sciences for Development of siRNA Therapeutics in China 2Life Technologies Signs Licensing Agreement with Suzhou Ribo Life Sciences for Development of siRNA Therapeutics in China 3Life Technologies Signs Licensing Agreement with Suzhou Ribo Life Sciences for Development of siRNA Therapeutics in China 4Specialty Coating Systems gibt die Einführung einer neuen antimikrobiellen Parylene-Technologie bekannt 2
Headlight module is mounted on UltraLite Plus headband....
... ICP Monitoring System provides ... intracranial pressure at the ... levels. The information is ... through a hydrostatic column ...
Slightly curved blunt dissector, double-ended. Length 11 1/2" (272 mm)...
Leroy-Raney scalp clips, sterile, disposable, plastic, ten clips/package....
Medicine Products: